UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): April 25, 2007
LYONDELL CHEMICAL COMPANY
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
1-10145 95-4160558
(Commission File Number) (I.R.S. Employer Identification No.)
1221 McKinney Street, Suite 700, Houston, Texas 77010
(Address of principal executive offices) (Zip Code)
(713) 652-7200
(Registrant's telephone number, including area code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (seeGeneral Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events
On April 25, 2007, the Board of Directors of Lyondell Chemical Company ("Company") elected Dan F. Smith as Chairman of the Board of Directors of the Company, effective on May 3, 2007 after the election of directors at the Company's 2007 Annual Meeting of Shareholders. Mr. Smith, the Company's President and Chief Executive Officer, will succeed the Company's current Chairman of the Board, Dr. William T. Butler, who will retire from the Board of Directors on May 3, 2007 after the election of directors at the Company's 2007 Annual Meeting of Shareholders. In addition, the independent members of the Board of Directors elected Travis Engen as the Lead Director of the Board of Directors of the Company, effective on May 3, 2007 after the election of directors at the Company's 2007 Annual Meeting of Shareholders. The press release regarding this matter is being filed with this Current Report on Form 8-K as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
99.1 Press Release
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
LYONDELL CHEMICAL COMPANY
By:/s/ Kerry A. Galvin
Name: Kerry A. Galvin
Title: Senior Vice President and
General Counsel
Date: April 26, 2007
INDEX TO EXHIBITS
Exhibit
NumberDescription
Exhibit 99.1 Press Release